RaNA Therapeutics Announces $55 Million in Oversubscribed Series B Financing Led by Merck

By: via Benzinga
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- RaNA Therapeutics, a leader in the discovery and development of a new class of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.